NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEGASYS® 180710 pronounced peg-ah-sis contains the active ingredient peginterferon alfa-2a Consumer Medicine Information What is
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REVLIMID® (lenalidomide) Consumer Medicine Information WARNING: Revlimid (lenalidomide) is structurally related to ‘thalidomide’, which is
Star-shaped cells called astrocytes help the brain establish long-lasting memories, Salk researchers have discovered. The new work adds to a growing body of evidence that astrocytes, long considered
Characterized by repetitive movements or vocalizations known as tics, Tourette Syndrome is a neurodevelopmental disorder that plagues many adolescents. A study conducted by Yale researchers has trained adolescents
Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found. The aggressive
A genome-wide association study has identified five new genetic risk loci that can pass on risk for harmful alcohol use from parents to children, and confirmed one previously
A new mouse model for Joubert Syndrome has been developed by University of Bath scientists, who hope it will accelerate research to understand how the disease develops as
Alcohol is ubiquitous in Western society, and rates of excessive use among adults remain high. Excessive alcohol consumption is an established risk factor for atrial fibrillation (AF), but
The Neurometabolic Diseases research team at IDIBELL and CIBER of Rare Diseases (CIBERER), led by ICREA Professor Aurora Pujol, has uncovered a novel disease of children affecting the
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
